111 Capital Buys Shares of 5,431 Encompass Health Co. (NYSE:EHC)

111 Capital acquired a new stake in Encompass Health Co. (NYSE:EHC - Free Report) during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm acquired 5,431 shares of the company's stock, valued at approximately $502,000.

Several other hedge funds have also recently bought and sold shares of the company. Colonial Trust Co SC bought a new stake in shares of Encompass Health during the 4th quarter worth about $29,000. Transce3nd LLC bought a new stake in shares of Encompass Health during the 4th quarter worth about $40,000. CBIZ Investment Advisory Services LLC raised its position in shares of Encompass Health by 38.7% during the 4th quarter. CBIZ Investment Advisory Services LLC now owns 455 shares of the company's stock worth $42,000 after buying an additional 127 shares in the last quarter. V Square Quantitative Management LLC raised its position in shares of Encompass Health by 43.8% during the 4th quarter. V Square Quantitative Management LLC now owns 581 shares of the company's stock worth $54,000 after buying an additional 177 shares in the last quarter. Finally, Signaturefd LLC raised its position in shares of Encompass Health by 21.6% during the 4th quarter. Signaturefd LLC now owns 704 shares of the company's stock worth $65,000 after buying an additional 125 shares in the last quarter. 97.25% of the stock is currently owned by institutional investors.

Insider Transactions at Encompass Health

In related news, CEO Mark J. Tarr sold 118,384 shares of the business's stock in a transaction that occurred on Tuesday, May 20th. The shares were sold at an average price of $121.53, for a total transaction of $14,387,207.52. Following the transaction, the chief executive officer now directly owns 527,070 shares of the company's stock, valued at approximately $64,054,817.10. The trade was a 18.34% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, insider Elissa Joy Charbonneau sold 4,279 shares of the business's stock in a transaction that occurred on Tuesday, May 6th. The shares were sold at an average price of $116.61, for a total transaction of $498,974.19. Following the transaction, the insider now directly owns 11,958 shares in the company, valued at $1,394,422.38. The trade was a 26.35% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 132,663 shares of company stock valued at $16,034,082 over the last ninety days. Corporate insiders own 2.00% of the company's stock.

Wall Street Analysts Forecast Growth

A number of research firms have commented on EHC. William Blair restated an "outperform" rating on shares of Encompass Health in a research report on Friday, February 7th. KeyCorp boosted their price target on shares of Encompass Health from $122.00 to $135.00 and gave the stock an "overweight" rating in a research report on Tuesday, May 27th. Royal Bank of Canada boosted their price target on shares of Encompass Health from $110.00 to $125.00 and gave the stock an "outperform" rating in a research report on Monday, April 28th. Truist Financial reaffirmed a "buy" rating and issued a $135.00 price objective (up previously from $116.00) on shares of Encompass Health in a research note on Monday, April 28th. Finally, UBS Group lifted their price objective on shares of Encompass Health from $117.00 to $130.00 and gave the stock a "buy" rating in a research note on Monday, April 28th. Eight analysts have rated the stock with a buy rating and two have given a strong buy rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of "Buy" and an average target price of $122.71.

Encompass Health Trading Up 0.7%

Shares of Encompass Health stock traded up $0.85 during trading on Tuesday, hitting $121.70. The stock had a trading volume of 429,315 shares, compared to its average volume of 700,610. The stock has a 50 day simple moving average of $110.75 and a 200 day simple moving average of $102.30. The company has a market capitalization of $12.27 billion, a PE ratio of 27.29, a P/E/G ratio of 2.31 and a beta of 0.91. The company has a quick ratio of 1.04, a current ratio of 1.05 and a debt-to-equity ratio of 0.84. Encompass Health Co. has a 1 year low of $82.74 and a 1 year high of $122.09.

Encompass Health (NYSE:EHC - Get Free Report) last released its earnings results on Thursday, April 24th. The company reported $1.37 earnings per share for the quarter, topping the consensus estimate of $1.19 by $0.18. The business had revenue of $1.46 billion for the quarter, compared to the consensus estimate of $1.43 billion. Encompass Health had a net margin of 8.48% and a return on equity of 17.56%. The firm's quarterly revenue was up 10.6% compared to the same quarter last year. During the same period last year, the firm posted $1.12 earnings per share. On average, research analysts expect that Encompass Health Co. will post 4.8 EPS for the current fiscal year.

Encompass Health Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, July 15th. Stockholders of record on Tuesday, July 1st will be given a $0.17 dividend. This represents a $0.68 annualized dividend and a dividend yield of 0.56%. The ex-dividend date of this dividend is Tuesday, July 1st. Encompass Health's dividend payout ratio (DPR) is currently 14.05%.

Encompass Health Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.